Dr Reddy’s Lab to obtain AFM approval for Offer Memorandum

16 Nov 2012 Evaluate

Dr Reddy’s Laboratories intends to submit a draft of the Offer Memorandum for obtaining approval from the Netherlands Authority of Financial Markets (AFM), post to which the offer will be made by making the Offer memorandum publicly available.

Dr Reddy’s and OctoPlus have reached conditional agreement in connection with an intended public offer by the former, or its subsidiary , for all issued and outstanding ordinary shares in the capital of Octopus at an offer price of Euro 0.52 (cum dividend) for each OctoPlus share.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1253.60 -17.45 (-1.37%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×